Processa Pharmaceuticals's activity chart (see below) currently has 24 price targets and 22 ratings on display.
Analysts' price targets on this stock were met 47.78% of the time, taking 153.4 days on average.
Most recent stock forecast was given by from HC WAINWRIGHT on 02-Sep-2025. First documented stock forecast 07-Dec-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2024
$1
$2
1 years 2 months 19 days ago
(02-Sep-2025)
8/9 (88.89%)
$-3.7 (-78.72%)
235
Buy Since 19-Apr-2022
$1000
3 years 4 days ago
(16-Nov-2023)
0/2 (0%)
$670 (203.03%)
Buy Since 07-Dec-2020
$80
$300
3 years 7 months 17 days ago
(04-Apr-2023)
2/3 (66.67%)
$-165 (-67.35%)
297
Buy Since 02-Aug-2021
$4000
3 years 7 months 18 days ago
(03-Apr-2023)
0/4 (0%)
$2700 (207.69%)
What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PCSA (Processa Pharmaceuticals)?
Which analyst has the lowest performance score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?